Surely, the human arsenal is expansive beyond all limits, but it still doesn’t have anything more valuable than tendency of ours to grow on a consistent basis. This is because the stated tendency, over the years, has allowed us to hit upon some huge milestones, with technology appearing as a major member of the group. The reason why technology enjoys such an esteemed stature among people is down to its skill-set, which ushered us towards a reality that we couldn’t have imagined otherwise. Nevertheless, if we look a little bit closer, it should become clear how the whole runner was also very much inspired by the way we applied those skills across a real-world environment. The latter component was, in fact, what gave the creation a spectrum-wide presence, including a timely appearance on our healthcare block. Technology’s foray into healthcare was perfect with its timing as it came right when the sector was beginning to struggle against its own obsolete structure. This reality, fortunately for us, went through a complete overhaul under the new regime, but even after achieving such a monumental feat, the new and budding medtech concept will somehow continue to produce all the right goods. The same has turned increasingly evident over the recent past, and truth be told, a new development involving Movano Health will only make that trend bigger and better moving forward.
Movano Health, a medtech company based in Pleasanton, California, has officially teamed up with Novant Health to beta test its smart ring. Covering around 30 Novant employees, the program is expected to provide Movano with in-depth data across various metrics, such as steps, heart rate, blood oxygen levels, and sleep stages etc. Hold on, there is more. In order to contextualize that data, the company will seek weekly feedback from every user, alongside specific satisfaction scores that are supposed to be shared at the end of the program. Now, while this information will likely have a major utility in improving the device’s performance from a general standpoint, it will also, notably enough, help Movano’s all-important bid of getting an FDA approval for the same, with the company seemingly keen on marketing its ring as a medical device.
“The ring’s development as a medical device rather than a wellness wearable ensures it will provide an advanced level of accuracy that consumers and medical professionals can trust. While a few wearables obtain medical clearance on individual algorithms for metrics like ECG and AFib, Movano Health’s ring is designed per regulatory standards and built in a medical device manufacturing facility that meets ISO13485 and cGMP standards,” said John Mastrototaro, CEO of Movano Health.
You can argue how the market already has, at its disposal, an excess of wearable devices, and honestly, it will be a fair argument too. However, Movano’s take is a bit unique because it is designed specifically for women. The stated point is a huge differentiator, considering most wearables are designed for men before they are sized down for women “as an afterthought.” Hence, what Movano did was that it brought medical-grade capabilities and “trend-forward look of contemporary jewelry” together to satisfy a segment which has long been underserved.
Interestingly enough, this isn’t the only beta test program Movano has launched for its smart ring. Back in August 2022, the company initiated a similar test in collaboration with Stanford University’s Applied Sports Science Department.